Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014
2014 (English)In: Eurosurveillance, ISSN 1025-496X, E-ISSN 1560-7917, Vol. 19, no 30, 2-5 p., 20862Article in journal (Refereed) Published
We describe four cases in Sweden of verified treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg; n=3) or cefotaxime (500 mg; n=1) monotherapy. All the ceftriaxone treatment failures were caused by the internationally spreading multidrug-resistant gonococcal NG-MAST genogroup 1407 clone. Increased awareness of treatment failures is crucial particularly when antimicrobial monotherapy is used. Frequent test of cure and appropriate verification/falsification of suspected treatment failures, as well as implementation of recommended dual antimicrobial therapy are imperative.
Place, publisher, year, edition, pages
European Centre for Disease Prevention and Control (ECDC) , 2014. Vol. 19, no 30, 2-5 p., 20862
IdentifiersURN: urn:nbn:se:oru:diva-56395ISI: 000341245000001ScopusID: 2-s2.0-84928254092OAI: oai:DiVA.org:oru-56395DiVA: diva2:1082091